Medical releases
Medical releases
Results 1 – 10 of 140 for LYNPARZA (3.82 seconds)
Medical releases
Oncology
Meet AZN management at ASCO2020
Lynparza approved in the EU for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
AstraZeneca and Foundation Medicine enter strategic collaboration for Lynparza companion diagnostic assay
Lynparza approved in Japan for BRCA-mutated metastatic breast cancer
Lynparza approved in Japan for BRCA-mutated metastatic breast cancer
Lynparza receives approval in Japan for the treatment of advanced ovarian cancer
Lynparza nearly doubled the time patients lived without disease progression from germline BRCA-mutated metastatic pancreatic cancer
Lynparza™approved in the European Union as first-in-class treatment for advanced BRCA-mutated ovarian cancer